19-12825732-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001270441.2(RTBDN):c.664G>A(p.Gly222Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000654 in 1,590,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001270441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152172Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000630 AC: 13AN: 206426Hom.: 0 AF XY: 0.0000353 AC XY: 4AN XY: 113358
GnomAD4 exome AF: 0.0000382 AC: 55AN: 1438280Hom.: 0 Cov.: 38 AF XY: 0.0000392 AC XY: 28AN XY: 713648
GnomAD4 genome AF: 0.000322 AC: 49AN: 152290Hom.: 0 Cov.: 31 AF XY: 0.000255 AC XY: 19AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2024 | The c.760G>A (p.G254S) alteration is located in exon 7 (coding exon 7) of the RTBDN gene. This alteration results from a G to A substitution at nucleotide position 760, causing the glycine (G) at amino acid position 254 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at